4.6 Review

Therapeutic Benefit of Systematic Lymphadenectomy in Node-Negative Uterine-Confined Endometrioid Endometrial Carcinoma: Omission of Adjuvant Therapy

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer

Shayan Dioun et al.

Summary: This study examined the patterns and outcomes of sentinel lymph node (SLN) assessment in women with endometrial cancer. The study found that the use of SLN mapping is increasing over time, while the use of lymph node dissection is decreasing. SLN mapping is associated with lower morbidity compared with lymph node dissection, but it also significantly increases costs.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Oncology

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment

Alicia Leon-Castillo et al.

Summary: The study evaluates the clinical outcome of molecular subgroups in high-grade endometrial cancer (EC) patients staged with lymphadenectomy and those without adjuvant treatment. The molecular classification has strong prognostic value, independent of clinicopathological factors. The unfavorable prognosis of early-stage p53abn EC is not due to undetected lymph node metastasis, and the indolent behavior of POLEmut EC is independent of adjuvant treatment.

GYNECOLOGIC ONCOLOGY (2022)

Article Oncology

Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006)

Duygu Altin et al.

Summary: This study evaluated the diagnostic accuracy of the sentinel lymph node mapping algorithm in high-risk endometrial cancer patients. The algorithm showed high sensitivity and negative predictive value for tumors with non-endometrioid histology and deep myometrial invasion. Long-term survival studies are still needed, but the algorithm is considered an effective diagnostic tool.

GYNECOLOGIC ONCOLOGY (2022)

Article Oncology

Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging

Anna Torrent et al.

Summary: This study demonstrates that the use of dual tracer and dual injection site during the learning curve can improve the detection rate of Sentinel lymph nodes (SLN) in early-stage endometrial cancer patients and the detection rate of para-aortic SLNs.

CANCERS (2022)

Article Obstetrics & Gynecology

Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study

David Forsse et al.

Summary: This study assessed the impact of lymphadenectomy and adjuvant chemotherapy on patient-reported symptoms, function, and quality of life in endometrial cancer patients. The findings suggest that patients receiving adjuvant chemotherapy reported significantly reduced functioning and more symptoms up to 2 years after treatment.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Oncology

Robot-assisted versus laparoscopic minimally invasive surgery for the treatment of stage I endometrial cancer

Peter A. Argenta et al.

Summary: The study compared the intermediate and long-term outcomes of patients with Stage I endometrial cancer who underwent robotic surgery or laparoscopy, finding that robotic surgery was associated with poorer recurrence-free survival, overall survival, and disease-specific survival.

GYNECOLOGIC ONCOLOGY (2022)

Article Oncology

Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases

Amy Jamieson et al.

Summary: This study assessed the association between molecular subtypes and lymph node metastases in endometrial cancer patients. The results showed a significant association between molecular subtypes and lymph node metastases. This information can be used to guide surgical treatment planning and reduce unnecessary lymph node staging.

GYNECOLOGIC ONCOLOGY (2022)

Article Oncology

Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification

Amy Jamieson et al.

Summary: This study measured the variation in practice across all aspects of endometrial cancer (EC) management and assessed the potential impact of molecular classification. The results showed significant differences in surgical practice, preoperative workup, and adjuvant therapy. Molecular subtyping was associated with patient survival. The study concluded that molecular classification has the potential to reduce disparities in EC care and guide treatment decisions.

GYNECOLOGIC ONCOLOGY (2022)

Review Medicine, General & Internal

Endometrial cancer

Emma J. Crosbie et al.

Summary: Endometrial cancer is the most common gynaecological cancer in high income countries, with a global rise in incidence. Obesity is the major underlying cause, posing challenges for diagnosis and treatment. Early presentation with postmenopausal bleeding ensures cure, but advanced cases have poor prognosis. Minimally invasive surgical staging and targeted chemotherapeutic strategies are important advances.

LANCET (2022)

Article Oncology

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma

Isao Otsuka et al.

Summary: This study evaluated the results of open surgery without adjuvant therapy in patients with uterine-confined intermediate- and high-risk endometrioid endometrial carcinoma. The five-year disease-specific survival rates were 100% and 90% for intermediate- and high-risk patients, respectively. The study suggests that open surgery with lymphadenectomy alone is an effective treatment option for these patients.

CURRENT ONCOLOGY (2022)

Article Oncology

Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer

Lina Salman et al.

Summary: Sentinel lymph node mapping is a viable alternative to full lymphadenectomy for evaluating lymphatic spread in clinical stage I endometrial cancer. While lymphadenectomy provides valuable information, most patients do not benefit from this procedure. SLN mapping offers prognostic information and avoids postoperative complications.

CURRENT ONCOLOGY (2022)

Article Obstetrics & Gynecology

Impact of uterine manipulator on oncological outcome in endometrial cancer surgery

Pablo Padilla-Iserte et al.

Summary: This study indicates that the use of a uterine manipulator in patients with early-stage endometrial cancer may lead to worse oncological outcomes, including a higher risk of recurrence and lower disease-free survival. Prospective trials are needed to confirm these results.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Article Obstetrics & Gynecology

Molecular characterization in the prediction of disease extent in endometrial carcinoma

Anne M. Kolehmainen et al.

Summary: This study assessed the capability of molecular classification to predict the stage of endometrial carcinoma, with POLE EDM independently predicting early stage disease. Despite p53 abn not being an independent predictor of advanced disease, its association with uterine risk factors could be useful in deciding the type of staging surgery.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)

Article Oncology

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin et al.

Summary: The European consensus conference on endometrial carcinoma in 2014 aimed to produce multi-disciplinary evidence-based guidelines. Since then, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) have decided to update the guidelines and cover new topics to improve care for women with endometrial carcinoma globally.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Article Obstetrics & Gynecology

Intraoperative tumor spill during minimally invasive hysterectomy for endometrial cancer: A survey study on experience and practice

Erica J. Chang et al.

Summary: A survey study was conducted among 220 U.S. gynecologic oncologists practicing minimally invasive hysterectomy for endometrial cancer to examine surgeon experiences and practices related to intraoperative tumor spill. The study found that many surgeons have experienced tumor spillage during minimally invasive hysterectomy for endometrial cancer, suggesting a need for further research on its incidence and impact on clinical outcomes.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)

Article Oncology

Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer

L. Philp et al.

Summary: In patients with HIR-EC treated with VBT, those who underwent minimally invasive hysterectomy had a shorter time to recurrence and higher risk of recurrence compared to those who underwent open hysterectomy. Further studies on the safety of minimally invasive surgery in high-intermediate risk patients are needed.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?

F. J. Backes et al.

Summary: This study assessed the associations between treatment and recurrence-free survival in patients with isolated tumor cells in sentinel lymph nodes and stage I/II endometrioid endometrial cancer. The results showed that the risk of retroperitoneal and/or distant recurrence is low regardless of treatment received by patients with SLN ITCs in stage I/II endometrioid EC.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes

Francesco Multinu et al.

Summary: The role of adjuvant chemotherapy in early-stage high-risk endometrioid endometrial cancer remains controversial. While the study found that adjuvant chemotherapy may improve oncologic outcomes, particularly in stage II patients with no deaths observed in those who received chemotherapy. Further research is needed to confirm these findings.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Article Surgery

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging

Maria C. Cusimano et al.

Summary: In women with intermediate- and high-grade endometrial cancer, sentinel lymph node biopsy (SLNB) showed a sensitivity of 96% and a negative predictive value of 99% for nodal metastasis detection. SLNB had acceptable diagnostic accuracy and improved the detection of node-positive cases compared with lymphadenectomy, suggesting it is a viable option for surgical staging in this patient population.

JAMA SURGERY (2021)

Article Oncology

Tumor Molecular Features Predict Endometrial Cancer Patients' Survival After Open or Minimally Invasive Surgeries

Yibo Dai et al.

Summary: This study analyzed 473 endometrial cancer patients from the TCGA database and found that the impact of different surgical approaches on patient prognosis is associated with their molecular features. A simplified molecular stratification model was established to show that patients with different molecular subtypes have varying survival outcomes based on the surgical approach.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

Endometrial endometrioid carcinoma, grade 1, is more aggressive in the elderly than in the young

Kazuhisa Hachisuga et al.

Summary: G1 endometrioid carcinoma in the elderly is more aggressive than in the young, and elderly status is an independent predictor of shorter progression-free survival. It is suggested that type 1 tumors can be subdivided into type 1a (young age at onset and indolent) and type 1b (old age at onset and relatively aggressive).

HISTOPATHOLOGY (2021)

Article Oncology

Impact of surgical approach on prevalence of positive peritoneal cytology and lymph-vascular invasion in patients with early-stage endometrial carcinoma: a National Cancer Database study

Dimitrios Nasioudis et al.

Summary: The study found that minimally invasive surgery in patients with early stage endometrioid endometrial carcinoma may be associated with a higher incidence of positive peritoneal cytology and lymph-vascular invasion. However, there was no difference in overall survival between patients who underwent open surgery and those who underwent minimally invasive surgery.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Article Obstetrics & Gynecology

Long-term survival of a patient with stage IIIC2 grade 3 endometrioid endometrial carcinoma treated with surgery alone

Isao Otsuka et al.

Summary: Pelvic and para-aortic lymphadenectomy may have therapeutic benefit in patients with high-grade endometrial carcinoma, particularly in the absence of p53 abnormality.

GYNECOLOGIC ONCOLOGY REPORTS (2021)

Article Oncology

Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study

Khaled Ghoniem et al.

Summary: The study evaluated oncologic outcomes in endometrial cancer patients with low-volume metastasis in the sentinel lymph nodes, finding that Non-endometrioid histology, lymphovascular space invasion, and uterine serosal invasion were independent risk factors for recurrence. Patients with any of these risk factors had poor prognosis even with adjuvant therapy. On the other hand, patients with isolated tumor cell and grade 1 endometrioid disease had favorable prognosis even without adjuvant therapy, suggesting a potential for withholding adjuvant therapy in this low-risk subgroup.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP)

Tomer Feigenberg et al.

Summary: This study evaluated the impact of local factors on disease recurrence risk in patients with high grade endometrial cancer who underwent minimally invasive surgery. Extracting a large uterus was found to be significantly associated with increased risk of intra-abdominal recurrence. Other factors such as stage and specimen weight were also linked to intra-abdominal recurrence.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes

Emad Matanes et al.

Summary: This study evaluated the prognostic value of LVSI in endometrial cancer patients and found that the prognostic value disappears in patients with negative nodes after SLN staging, while LVSI still has favorable survival outcomes in patients who have undergone LND.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR)

Martina Aida Angeles et al.

Summary: The transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR) method demonstrates high accuracy in detecting lymph node metastases in patients with intermediate and high-risk endometrial cancer, particularly in identifying paraaortic involvement.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2021)

Article Medicine, General & Internal

Survival rates of patients who undergo minimally invasive surgery for endometrial cancer with cervical involvement

Sang Il Kim et al.

Summary: This study compared the oncologic outcomes of patients with intermediate-risk endometrial cancer who underwent minimally invasive surgery versus open surgery. There was no significant difference in recurrence rate, disease-free survival, and overall survival between the two surgical approaches for stage IB endometrial cancer patients. However, for stage II endometrial cancer patients, those who underwent minimally invasive surgery had a significantly higher recurrence rate and lower disease-free survival compared to those who underwent open surgery, although overall survival was similar.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

Article Oncology

Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer

Glauco Baiocchi et al.

ANNALS OF SURGICAL ONCOLOGY (2020)

Article Oncology

Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus

Michaela Onstad et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Article Obstetrics & Gynecology

Systematic lymphadenectomy in early stage endometrial cancer

Atanas Ignatov et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)

Review Medicine, General & Internal

Endometrial Cancer

Karen H. Lu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Immunology

Does patient age influence anti-cancer immunity?

Graham Pawelec

SEMINARS IN IMMUNOPATHOLOGY (2019)

Review Biochemistry & Molecular Biology

Cutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible Mechanisms

Isao Otsuka

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Pathology

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

Tjalling Bosse et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

Article Medicine, General & Internal

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

Pedro T. Ramirez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

Alexander Melamed et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Oncology

Clinicopathological Features of Early and Late Recurrence of Endometrial Carcinoma After Surgical Resection

Akimasa Takahashi et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)

Editorial Material Medicine, General & Internal

Laparoscopic Hysterectomy for Endometrial Cancer A Procedure 25 Years in the Making

Jason D. Wright

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

M. B. Faries et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Obstetrics & Gynecology

Accuracy of Endometrial Sampling in Endometrial Carcinoma A Systematic Review and Meta-analysis

Nicole C. M. Visser et al.

OBSTETRICS AND GYNECOLOGY (2017)

Review Obstetrics & Gynecology

Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis

Anna Jo Bodurtha Smith et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)

Article Oncology

The nature of early-stage endometrial cancer recurrence-A national cohort study

Mette Moustgaard Jeppesen et al.

EUROPEAN JOURNAL OF CANCER (2016)

Article Oncology

Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms

Yasuhiko Ebina et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Obstetrics & Gynecology

TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers

Anne M. Schultheis et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)

Article Oncology

Survival advantage of lymphadenectomy in endometrial cancer

Holm Eggemann et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)

Article Oncology

Comparative Effectiveness of Minimally Invasive Hysterectomy for Endometrial Cancer

Jason D. Wright et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Oncology

The risk of lymphedema after postoperative radiation therapy in endometrial cancer

Devarati Mitra et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2016)

Article Obstetrics & Gynecology

Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer

Christina Fotopoulou et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)

Review Oncology

The role of vaginal cuff brachytherapy in endometrial cancer

Matthew M. Harkenrider et al.

GYNECOLOGIC ONCOLOGY (2015)

Editorial Material Oncology

A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma

Michael Frumovitz et al.

GYNECOLOGIC ONCOLOGY (2014)

Article Oncology

Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments

Takashi Mitamura et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2014)

Article Surgery

Port site and peritoneal metastases after robot-assisted radical prostatectomy

Omer Acar et al.

INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2014)

Article Oncology

Survival Analysis of Endometrial Cancer Patients With Positive Lymph Nodes

Aaron P. Brown et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)

Article Oncology

Long-Term Outcomes After Pelvic Radiation for Early-Stage Endometrial Cancer

Mathias Onsrud et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Multidisciplinary Sciences

Integrated genomic characterization of endometrial carcinoma

Gad Getz et al.

NATURE (2013)

Article Otorhinolaryngology

Selection of irrigation fluid to eradicate free cancer cells during head and neck cancer surgery

J. Hun Hah et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)

Article Obstetrics & Gynecology

Nodal Metastasis Risk in Endometrioid Endometrial Cancer

Michael R. Milam et al.

OBSTETRICS AND GYNECOLOGY (2012)

Article Pathology

Lymph Node Counts in Endometrial Cancer: Expectations Versus Reality

Elizabeth D. Euscher et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)

Article Oncology

Therapeutic Role of Lymphadenectomy for Cervical Cancer

Monjri Shah et al.

CANCER (2011)

Editorial Material Oncology

ASTEC lymphadenectomy and radiation therapy studies: Are conclusions valid?

W. T. Creasman et al.

GYNECOLOGIC ONCOLOGY (2010)

Article Oncology

Second neoplasms in survivors of endometrial cancer: Impact of radiation therapy

Sanjeev Kumar et al.

GYNECOLOGIC ONCOLOGY (2009)

Article Oncology

Patterns of Failure for Conservatively Managed Surgical Stage I Uterine Carcinosarcoma Implications for Adjuvant Therapy

Charles A. Leath et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)

Article Medicine, General & Internal

Efficacy of systematic pelvic endometrial cancer (MRC ASTEC trial): a randomised study

H. Kitchener et al.

LANCET (2009)

Article Obstetrics & Gynecology

Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?

Nadeem R. Abu-Rustum et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)

Article Oncology

Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

Pierluigi Benedetti Panici et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Article Obstetrics & Gynecology

Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors

Gloria S. Huang et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)

Review Oncology

Role of complete lymphadenectomy in endometrioid uterine cancer

John K. Chan et al.

LANCET ONCOLOGY (2007)

Article Oncology

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer

KM Alektiar et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)

Article Oncology

Endometrial carcinoma: paraaortic dissemination

A Mariani et al.

GYNECOLOGIC ONCOLOGY (2004)

Article Oncology

Sentinel lymph node detection in patients with endometrial cancer

H Niikura et al.

GYNECOLOGIC ONCOLOGY (2004)

Article Oncology

Laparoscopic port-site metastases: etiology and prevention

PT Ramirez et al.

GYNECOLOGIC ONCOLOGY (2003)

Article Medicine, General & Internal

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults

EE Calle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Oncology

Pulmonary metastasis from endometrial carcinoma

I Otsuka et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)

Article Oncology

Hematogenous dissemination in corpus cancer

A Mariani et al.

GYNECOLOGIC ONCOLOGY (2001)